The role of TRAIL in mediating autophagy in myositis skeletal muscle: A potential nonimmune mechanism of muscle damage

Arthritis and Rheumatism

Volumn 63, Issue 11, 2011, Pages 3448-3457

  Alger, Heather M ^a   Raben, Nina ^b   Pistilli, Emidio ^c   Francia, Dwight L ^a   Rawat, Rashmi ^d   Getnet, Derese ^e   Ghimbovschi, Svetlana ^a   Chen, Yi Wen ^a   Lundberg, Ingrid E ^f   Nagaraju, Kanneboyina ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; AUTOPHAGY PROTEIN 5; CASPASE 3; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN ATG4B; PROTEIN ATG7; PROTEIN GABARAP; PROTEIN GABARAPL1; PROTEIN MAP1LC3A; PROTEIN PIK3C3; PROTEIN PIK3R4; PROTEIN RAB24; PROTEIN ULK2; PROTEIN WIPI1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; BLOOD VESSEL; CELL CULTURE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DUCHENNE MUSCULAR DYSTROPHY; GASTROCNEMIUS MUSCLE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPHOCYTE; MOUSE; MUSCLE CELL; MYOSITIS; NONHUMAN; PATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; AUTOPHAGY; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MYOSITIS; NF-KAPPA B; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 80155204615     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30530     Document Type: Article

References (47)

1. Nagaraju K, Casciola-Rosen L, Lundberg I, Rawat R, Cutting S, Thapliyal R, et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 2005; 52: 1824-35. (Pubitemid 40852891)
2. Henriques-Pons A, Nagaraju K,. Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis. Curr Opin Rheumatol 2009; 21: 581-7.
3. Dastmalchi M, Alexanderson H, Loell I, Stahlberg M, Borg K, Lundberg IE, et al. Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis. Arthritis Rheum 2007; 57: 1303-10. (Pubitemid 47585478)
4. Edinger AL, Thompson CB,. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004; 16: 663-9. (Pubitemid 39463117)
5. Fukuda T, Ewan L, Bauer M, Mattaliano RJ, Zaal K, Ralston E, et al. Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol 2006; 59: 700-8.
6. Bursch W, Karwan A, Mayer M, Dornetshuber J, Frohwein U, Schulte-Hermann R, et al. Cell death and autophagy: cytokines, drugs, and nutritional factors. Toxicology 2008; 254: 147-57.
7. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA,. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-92.
8. Tartaglia LA, Rothe M, Hu YF, Goeddel DV,. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993; 73: 213-6. (Pubitemid 23123300)
9. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM,. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997; 277: 815-8. (Pubitemid 27366732)
10. Los M, Burek CJ, Stroh C, Benedy KK, Hug H, Markiewicz A,. Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design. Drug Discov Today 2003; 8: 67-77. (Pubitemid 36139900)
11. Nagaraju K, Casciola-Rosen L, Rosen A, Thompson C, Loeffler L, Parker T, et al. The inhibition of apoptosis in myositis and in normal muscle cells. J Immunol 2000; 164: 5459-65. (Pubitemid 30305230)
12. Schneider C, Gold R, Dalakas MC, Schmied M, Lassmann H, Toyka KV, et al. MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis. J Neuropathol Exp Neurol 1996; 55: 1205-9. (Pubitemid 26397139)
13. Tews DS, Goebel HH,. Cell death and oxidative damage in inflammatory myopathies. Clin Immunol Immunopathol 1998; 87: 240-7. (Pubitemid 28285439)
14. Li M, Dalakas MC,. Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies. J Neuroimmunol 2000; 106: 1-5. (Pubitemid 30256071)
15. Mills KR, Reginato M, Debnath J, Queenan B, Brugge JS,. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proc Natl Acad Sci U S A 2004; 101: 3438-43. (Pubitemid 38338213)
16. Zhao Y, Fedczyna TO, McVicker V, Caliendo J, Li H, Pachman LM,. Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease. Clin Immunol 2007; 125: 165-72. (Pubitemid 47570110)
17. + children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 2002; 168: 4154-63. (Pubitemid 34298424)
18. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673-82. (Pubitemid 26091143)
19. Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA,. TRAIL-mediated apoptosis requires NF-IκB inhibition and the mitochondrial permeability transition in human hepatoma cells. Hepatology 2002; 36: 1498-508. (Pubitemid 35403540)
20. Bohan A, Peter JB,. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
21. Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E, et al. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A 2000; 97: 9209-14. (Pubitemid 30626699)
22. Raben N, Shea L, Hill V, Plotz P,. Monitoring autophagy in lysosomal storage disorders. Methods Enzymol 2009; 453: 417-49.
23. Lamason R, Zhao P, Rawat R, Davis A, Hall JC, Chae JJ, et al. Sexual dimorphism in immune response genes as a function of puberty. BMC Immunol 2006; 7: 2.
24. Bakay M, Wang Z, Melcon G, Schiltz L, Xuan J, Zhao P, et al. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain 2006; 129: 996-1013.
25. Behrens L, Bender A, Johnson MA, Hohlfeld R,. Cytotoxic mechanisms in inflammatory myopathies: co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells. Brain 1997; 120: 929-38. (Pubitemid 27259544)
26. Inukai A, Kobayashi Y, Ito K, Doyu M, Takano A, Honda H, et al. Expression of Fas antigen is not associated with apoptosis in human myopathies. Muscle Nerve 1997; 20: 702-9. (Pubitemid 27197723)
27. Olive M, Martinez-Matos JA, Montero J, Ferrer I,. Apoptosis is not the mechanism of cell death of muscle fibers in human muscular dystrophies and inflammatory myopathies. Muscle Nerve 1997; 20: 1328-30. (Pubitemid 27415526)
28. Engel AG, Banker BQ,. Ultrastructural changes in diseased muscle. In:, Engel AG, Franzini-Armstrong C, editors. Myology: basic and clinical. 3rd ed. New York: McGraw-Hill; 2004. p. 749-889.
29. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 2005; 64: 113-22. (Pubitemid 40349309)
30. Nevo Y, Pestronk A,. Neonatal perifascicular myopathy. Pediatr Neurol 1996; 15: 150-2. (Pubitemid 26315035)
31. Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E, et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 2005; 201: 591-601. (Pubitemid 40289549)
32. Ichikawa K, Liu W, Fleck M, Zhang H, Zhao L, Ohtsuka T, et al. TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis. J Immunol 2003; 171: 1061-9. (Pubitemid 36871423)
33. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-IκB. Immunity 1997; 7: 831-6. (Pubitemid 28064896)
34. Han J, Hou W, Goldstein LA, Lu C, Stolz DB, Yin XM, et al. Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. J Biol Chem 2008; 283: 19665-77.
35. Park KJ, Lee SH, Kim TI, Lee HW, Lee CH, Kim EH, et al. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells. Cancer Res 2007; 67: 7327-34.
36. Hu WH, Johnson H, Shu HB,. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-IκB and JNK activation and apoptosis through distinct pathways. J Biol Chem 1999; 274: 30603-10.
37. Park KJ, Lee SH, Lee CH, Jang JY, Chung J, Kwon MH, et al. Upregulation of Beclin-1 expression and phosphorylation of Bcl-2 and p53 are involved in the JNK-mediated autophagic cell death. Biochem Biophys Res Commun 2009; 382: 726-9.
38. Chang YP, Tsai CC, Huang WC, Wang CY, Chen CL, Lin YS, et al. Autophagy facilitates IFN-γ-induced Jak2-STAT1 activation and cellular inflammation. J Biol Chem 2010; 285: 28715-22.
39. Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S, et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 2006; 26: 9220-31. (Pubitemid 44904418)
40. Yorimitsu T, Nair U, Yang Z, Klionsky DJ,. Endoplasmic reticulum stress triggers autophagy. J Biol Chem 2006; 281: 30299-304. (Pubitemid 44537037)
41. Mizushima N, Yamamoto A, Hatano M, Kobayashi Y, Kabeya Y, Suzuki K, et al. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 2001; 152: 657-68.
42. Eskelinen EL,. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med 2006; 27: 495-502.
43. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19: 5720-8.
44. Mijaljica D, Prescott M, Devenish RJ,. Endoplasmic reticulum and Golgi complex: contributions to, and turnover by, autophagy. Traffic 2006; 7: 1590-5. (Pubitemid 44742361)
45. Tanida I, Ueno T, Kominami E,. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 2004; 36: 2503-18. (Pubitemid 39119762)
46. Ralston E, Lu Z, Ploug T,. The organization of the Golgi complex and microtubules in skeletal muscle is fiber type-dependent. J Neurosci 1999; 19: 10694-705. (Pubitemid 30235716)
47. Li CK, Knopp P, Moncrieffe H, Singh B, Shah S, Nagaraju K, et al. Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis. Am J Pathol 2009; 175: 1030-40.